Arkolith/Insider Trading/RLAY/Form 4

Patel Sanjiv

President and CEO, DirectorRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Nov 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$435K
Net Open-Market Flow
-$435K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 3, 2025Sell(S)62K$7.00$435K703K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-264700) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML